Malaysia · Delayed Price · Currency is MYR KLSE:HSPLANT Statistics
Total Valuation
KLSE:HSPLANT has a market cap or net worth of MYR 1.57 billion. The enterprise value is 973.56 million.
| Market Cap | 1.57B |
| Enterprise Value | 973.56M |
Important Dates
The last earnings date was Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | Sep 11, 2025 |
Share Statistics
KLSE:HSPLANT has 799.69 million shares outstanding.
| Current Share Class | 799.69M |
| Shares Outstanding | 799.69M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 9.42% |
| Float | 212.39M |
Valuation Ratios
The trailing PE ratio is 8.58 and the forward PE ratio is 10.17.
| PE Ratio | 8.58 |
| Forward PE | 10.17 |
| PS Ratio | 2.10 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | 10.37 |
| P/OCF Ratio | 6.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.97, with an EV/FCF ratio of 6.44.
| EV / Earnings | 5.33 |
| EV / Sales | 1.30 |
| EV / EBITDA | 2.97 |
| EV / EBIT | 4.03 |
| EV / FCF | 6.44 |
Financial Position
The company has a current ratio of 11.12, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.12 |
| Quick Ratio | 9.24 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.40 |
| Interest Coverage | 77.51 |
Financial Efficiency
Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 7.27%.
| Return on Equity (ROE) | 9.06% |
| Return on Assets (ROA) | 6.03% |
| Return on Invested Capital (ROIC) | 7.27% |
| Return on Capital Employed (ROCE) | 9.82% |
| Revenue Per Employee | 93,645 |
| Profits Per Employee | 22,916 |
| Employee Count | 7,968 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 4.57 |
Taxes
In the past 12 months, KLSE:HSPLANT has paid 56.06 million in taxes.
| Income Tax | 56.06M |
| Effective Tax Rate | 23.49% |
Stock Price Statistics
The stock price has increased by +10.98% in the last 52 weeks. The beta is -0.01, so KLSE:HSPLANT's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +10.98% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 37.87 |
| Average Volume (20 Days) | 495,345 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:HSPLANT had revenue of MYR 746.16 million and earned 182.59 million in profits. Earnings per share was 0.23.
| Revenue | 746.16M |
| Gross Profit | 311.36M |
| Operating Income | 241.77M |
| Pretax Income | 238.65M |
| Net Income | 182.59M |
| EBITDA | 301.68M |
| EBIT | 241.77M |
| Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has 653.62 million in cash and 59.80 million in debt, giving a net cash position of 593.82 million or 0.74 per share.
| Cash & Cash Equivalents | 653.62M |
| Total Debt | 59.80M |
| Net Cash | 593.82M |
| Net Cash Per Share | 0.74 |
| Equity (Book Value) | 2.06B |
| Book Value Per Share | 2.57 |
| Working Capital | 733.40M |
Cash Flow
In the last 12 months, operating cash flow was 232.72 million and capital expenditures -81.57 million, giving a free cash flow of 151.15 million.
| Operating Cash Flow | 232.72M |
| Capital Expenditures | -81.57M |
| Free Cash Flow | 151.15M |
| FCF Per Share | 0.19 |
Margins
Gross margin is 41.73%, with operating and profit margins of 32.40% and 24.47%.
| Gross Margin | 41.73% |
| Operating Margin | 32.40% |
| Pretax Margin | 31.98% |
| Profit Margin | 24.47% |
| EBITDA Margin | 40.43% |
| EBIT Margin | 32.40% |
| FCF Margin | 20.26% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 6.51%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 6.51% |
| Dividend Growth (YoY) | 83.82% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 54.75% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.51% |
| Earnings Yield | 11.65% |
| FCF Yield | 9.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:HSPLANT has an Altman Z-Score of 3.91 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.91 |
| Piotroski F-Score | 7 |